Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: A systematic review

American Journal of Chinese Medicine

Volumn 39, Issue 6, 2011, Pages 1061-1074

  Zeng, Xiao Xi ^a   Bian, Zhao Xiang ^a   Wu, Tai Xiang ^a   Fu, Shu Fei ^a   Ziea, Eric ^a   Woon, Wong Taam Chi ^b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

Chronic Hepatitis B; Distribution; Epidemiology Study; Syndrome Differentiation; Systematic Review; Traditional Chinese Medicine

Indexed keywords

CHINESE MEDICINE; CHRONIC HEPATITIS; DISEASE COURSE; DISEASE SEVERITY; EMBASE; GALLBLADDER DISEASE; HEPATITIS B; HUMAN; KIDNEY DISEASE; LIVER CIRRHOSIS; LIVER DEPRESSION AND SPLEEN DEFICIENCY; LIVER DISEASE; LIVER GALLBLADDER DAMPNESS HEAT; LIVER KIDNEY YIN DEFICIENCY; MEDLINE; POPULATION DISTRIBUTION; REVIEW; SPLEEN DISEASE; SPLEEN KIDNEY YANG DEFICIENCY; SYNDROME; SYSTEMATIC REVIEW; VENOUS STASIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; YOUNG ADULT;

EID: 81155139258     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009408     Document Type: Review

References (37)

1. Cai, H., S. Xu and P. Li. Relationship between the traditional Chinese medicine syndromes of chronic hepatitis B and the antiviral effect of adefovir dipivoxil. J. New Chin. Med. 39: 28-29, 2007.
2. Chen, W., Q. Wu, B. Chen, M. Ke, L. Guo and X. Liu. Measurement study of disease differentiation treatment based on standard syndrome differentiation. J. Chin. Integr. Med. 7: 401-406, 2009.
3. Churchill, W. Implications of evidence based medicine for complimentary and alternative medicine. J. Chin. Med. 59: 32-35, 1999.
4. Cong, C. Lamifudin treats chronic hepatitis B in different TCM types. J. Zhejiang Univ. Tradit. Chin. Med. 30: 251-253, 2006.
5. Cui, X., Y. Wang, N. Kokudo, D. Fang and W. Tang. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. BioScience Trends 4: 39-47, 2010.
6. Ding, W.J., Y.Z. Zeng, W.H. Li, T.E. Zhang, W.W. Liu, X.K. Teng, Y.X. Ma, SL. Yan, J.M. Wan and M.Q. Wang. Identification of linkage disequilibrium SNPs from a kidney-yang deficiency syndrome pedigree. Am. J. Chin. Med. 37: 427-438, 2009.
7. Flaws B. and S. Philippe. The treatment of modern Western medical diseases with Chinese medicine. Blue Poppy Press, Boulder, 2001.
8. Fruehauf, J. Chinese medicine in crisis: science, politics and the making of "TCM". J. Chin. Med. 16: 1-9, 1999.
9. Infectious and Parasitic Diseases Committee, Hepatology Committee of Chinese Medical Association. Treatment and prevention project for virus hepatitis. Chin. J. Hepatol. 8: 324-329, 2000.
10. Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association. The standards of TCM differential syndromes of viral hepatitis. J. Tradit. Chin. Med. 5: 39-40, 1992.
11. Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11: 97-107, 2004.
12. Lee, W.M. Hepatitis B virus infection. N Engl. J. Med. 337: 1733-1745, 1997.
13. Li, S., N. Zhang, Z. Li, H. Ding and Y. Ye. Decision tree diagnostic model of gan-dan damp-heat syndrome and gan-stagnancy pi-deficiency syndrome in patients with chronic hepatitis B. Chin. J. Integr. Chin. West. Med. 29: 993-996, 2009.
14. Li, Y., T. Wu, G. Liu, J. Li, T. Li, H. Shang, B. Zhang, Z. Bian and D. Moher. The strategy of Chinese Evidence-Based Medicine Center for promoting the modernization of traditional Chinese medicine. Chin. J. Evid. Based Med. 7: 159-161, 2007.
15. Liu, J.P., H. McIntosh and H. Lin. Chinese medicinal herbs for chronic hepatitis B. Cochrane Database Syst. Rev. (1): CD001940, 2001a.
16. Liu, J.P., H. McIntosh and H. Lin. Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection. Cochrane Database Syst. Rev. (2): CD002231, 2001b.
17. Liu, Z., X. Tao and S. Liu. Study on traditional Chinese medicine syndrome characteristics of chronic hepatitis B. Chin. J. Basic Med. Tradit. Chin. Med. 16: 229-231, 2010.
18. Lok, A.S.F. and B.J. McMahon. AASLD practice guidelines: chronic hepatitis B. Hepatology 45: 507-539, 2007.
19. Lu, A.P., H.W. Jia, C. Xiao and Q.P. Lu. Theory of traditional Chinese medicine and therapeutic method of diseases. World J. Gastroenterol. 10: 1854-1856, 2004.
20. McCulloch, M., M. Broffman, J. Gao and J.M. Colford. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. Am. J. Public Health 92: 1619-1627, 2002.
21. Perz, J.F., GL. Armstrong, LA. Farrington, Y.J.F. Hutin and B.P. Bell. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45: 529-538, 2006.
22. Sanderson, S., I.D. Tatt and J.P. Higgins. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int. J. Epidemiol. 36: 666-676, 2007.
23. Shea, J.L. Applying evidence-based medicine to traditional Chinese medicine: debate and strategy. J. Altern. Complement. Med. 12: 255-226, 2006.
24. Shi, W., X. Miu, Y. Huang and Z. Chen. Correlation between traditional Chinese medicine syndromes and T cell markers and cytokines in patients with chronic hepatitis B. World J. Digestol. 13: 1364-1367, 2005.
25. Shi, W. and D. Ye. An analysis on related factors of traditional Chinese medicine symptoms of chronic hepatitis B. Chin. J. Dis. Control Prev. 9: 641-642, 2005.
26. Song, J. and K. Chen. Set up clinical therapeutic guideline in traditional medicine urgently. Chin. J. Integr. Chin. West. Med. 26: 581-584, 2006.
27. Wang, B.E. Treatment of chronic liver diseases with traditional Chinese medicine. J. Gastroenterol. Hepatol. 15: E67-E70, 2000.
28. Wang, W. and M. Xu. Correlation between traditional Chinese medicine syndromes and severity in patients with chronic hepatitis B. Jiangsu J. Tradit. Chin. Med. 27: 33, 2005.
29. Wei, H., G. Ji and P. Zheng. Study of standardization of syndrome diagnosis: an analysis of current status. J. Chin. Integr. Med. 5: 115-121, 2007.
30. Xu, F., F. Wang, Y. Wang, J. Luo and M. Xiao. Correlation between efficacy of adefovir dipivoxil and traditional Chinese medicine syndromes in chronic hepatitis B patients with lamifudin resistance. Chongqing Med. J. 38: 1524-1525, 2009.
31. Xutian, S., J. Zhang and W. Louise. New exploration and understanding of traditional Chinese medicine. Am. J. Chin. Med. 37: 411-426, 2009.
32. Yu, Y., F. Zhou, R. Liao, X. Zhou and Q. Luo. Comparison of different diagnosis and correlated indexes in patients with chronic hepatitis B positive or negative HBeAg. Mod. J. Integr. Tradit. Chin. West. Med. 18: 8-10, 2009.
33. Zhang, Y. and B. Wei. Criteria of clinical diagnosis, syndrome differentiation and efficacy assessment for cirrhosis. J. Chin. Integr. Med. 14: 237, 1994.
34. Zhao, J., Q. Li, J. Jia, G. Yuan and W. Cao. Relationship between the traditional Chinese medicine syndromes of chronic hepatitis B and the antiviral curative effect by lamivudine. Liaoning J. Tradit. Chin. Med. 35: 1529-1530, 2008.
35. Zheng, X.Y. Guideline for Clinical Research on New Chinese Medicine Drugs. China Medical Science and Technology Press, Beijing, 2002.
36. Zhu, C., X. Yin and Z. Zhang. Correlation between traditional Chinese medicine syndromes and virus replication in patients with chronic hepatitis B. Liaoning J. Tradit. Chin. Med. 34: 705-707, 2007.
37. Zhu, L., H. Meng, J. Jiang and Y. Gao. Study on TCM syndrome typing of chronic hepatitis B. Chin. J. Integr. Chin. West. Med. 28: 20-23, 2008.